References
- Centers for Disease Control and PreventionNational Diabetes Fact Sheet: General information and national estimates on diabetes in the United States, 2005Atlanta, GACenter for Disease Control2005
- EppensMCCraigMECusumanoJPrevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetesDiabetes Care2006291300130616732012
- Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research groupArch Ophthalmol1985103179618062866759
- LiazosEBroadbentDMBeareNKumarNSpontaneous resolution of diabetic macular oedema after discontinuation of thiazolidenedionesDiabet Med20082586086218644073
- MossSEKleinRKleinBEThe 14-year incidence of visual loss in a diabetic populationOphthalmology199810599810039627648
- BandelloFLanzettaPMenchiniUWhen and how to do a grid laser for diabetic macular edemaDoc Ophthalmol19999741541910896358
- AdamisAPMillerJWBernalMTIncreased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol19941184454507943121
- BrooksHLJrCaballeroSJrNewellCKVitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinoloneArch Ophthalmol20041221801180715596583
- LamDSChanCKMohamedSIntravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomesOphthalmology20071142162216717459479
- CelliniMPazzagliaAZampariniELeonettiPCamposECIntravitreal vs subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edemaBMC Ophthalmol20088518366650
- ShimuraMNakazawaTYasudaKShionoTNishidaKPretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedemaBr J Ophthalmol20079144945417077114
- Vasconcelos-SantosDVNehemyPGSchachatAPNehemyMBSecondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factorsRetina20082857358018398360
- FurlaniBAMeyerCHRodriguesEBEmerging pharmacotherapies for diabetic macular edemaExpert Opin Emerg Drugs20071259160317979601
- HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med20043502335234215175435
- RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degenerationOphthalmic Surg Lasers Imaging20053633133516156152
- ScottIUEdwardsARBeckRWA phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edemaOphthalmology20071141860186717698196
- SoheilianMRamezaniABijanzadehBIntravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edemaRetina2007271187119518046223
- HaritoglouCKookDNeubauerAIntravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edemaRetina200626999100517151486
- KumarASinhaSIntravitreal bevacizumab (Avastin) treatment of diffuse diabetic macular edema in an Indian populationIndian J Ophthalmol20075545145517951903
- ChunDWHeierJSToppingTMDukerJSBankertJMA pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edemaOphthalmology20061131706171217011952
- NguyenQDTatlipinarSShahSMVascular endothelial growth factor is a critical stimulus for diabetic macular edemaAm J Ophthalmol200614296196917046701
- CunninghamETJrAdamisAPAltaweelMA phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaOphthalmology20051121747175716154196
- JonasJBSpandauUHSchlichtenbredeFShort-term complications of intravitreal injections of triamcinolone and bevacizumabEye20082259059118292795
- GandorferAMessmerEMUlbigMWKampikAResolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membraneRetina20002012613310783944
- HarbourJWSmiddyWEFlynnHWJrRubsamenPEVitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membraneAm J Ophthalmol19961214054138604734
- FigueroaMSContrerasINovalSSurgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edemaRetina20082842042618327133
- PatelJIHykinPGSchadtMLuongVFitzkeFGregorZJPars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edemaRetina20062651316395132
- YanyaliAHorozogluFCelikENohutcuAFLong-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edemaRetina20072755756617558316
- HoganPDallTNikolovPEconomic costs of diabetes in the US in 2002Diabetes Care20032691793212610059